<DOC>
	<DOCNO>NCT01149538</DOCNO>
	<brief_summary>The purpose study determine choline bitartrate administer daily child prenatal alcohol exposure , age 2.5 5 , potential treatment brain development cognitive functioning .</brief_summary>
	<brief_title>Postnatal Choline Supplementation Children With Prenatal Alcohol Exposure</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fetal Alcohol Spectrum Disorders</mesh_term>
	<mesh_term>Neurodevelopmental Disorders</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Choline</mesh_term>
	<criteria>Available parent legal guardian capable participate informed consent process Documented history heavy prenatal alcohol exposure ( selfreport , social service record , adoption record ) presence facial dysmorphology characteristic FASD Evidence cognitive deficit least one neurocognitive domain History neurological condition ( ex . epilepsy , cerebral palsy , traumatic brain injury ) History medical condition know affect brain function History neurodevelopmental disorder ( ex . autism , syndrome ) History low birthweight ( &lt; 1500 gram ) History prenatal exposure drug alcohol , nicotine , caffeine</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>5 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>FASD</keyword>
	<keyword>FAS</keyword>
	<keyword>Alcohol</keyword>
	<keyword>Prenatal Alcohol</keyword>
</DOC>